THIS NEW PROSPECT FOR WEIGHT MANAGEMENT ?

Researchers are rapidly examining retatrutide, a promising medication created by Eli Lilly, as a potential advance in physique management. Unlike many previous approaches, retatrutide is a dual -action compound targeting simultaneously GLP-1 and GIP, hormones that affect hunger and blood glucose